Prospective evaluation of breast cancer at Brazilian institutions – Project AMAZONA III
Real-World Data on First-line Treatment of Hormone Receptor-positive, HER2-negative, Metastatic Breast Cancer in Brazil (LACOG 0221) – BRAVE Study
Evaluation of Sequencing of Anthracyclines and Taxanes for Locally Advanced HER2-negative Breast Cancer
OPEN FOR RECRUITMENT
MGH – International Breast Cancer Collaborative Project: Determination of an Endocrine Responsive Metastatic Breast Cancer Signature.
Metastatic breast cancer in Brazil: characterization of patients and treatments.
Evaluation of the attitude of premenopausal patients with breast cancer to the risk of loss of fertility caused by chemotherapy.
A randomized open-label, phase II study of lapatinib/capecitabine or lapatinib/vinorelbine or lapatinib/gemcitabine in subjects with Her2/neu amplified metastatic breast cancer patients progressing after taxanes treatment.
